IGM Biosciences files for $100 Million IPO

IGM Biosciences filed the paperwork for its IPO on 8/19/19. The company will raise up to $100 Million. IGM is pioneering the development of engineered IgM antibodies for cancer treatments. The company will trade on NASDAQ under the symbol "IGMS."